GlassScriptPhysician profile
Hazem T Hammad
NPI 1558572743
$56,758.65
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $12K · 2021: $17K · 2023: $17.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $17.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $53,814.04 | 2019-2021 | |
| Olympus Corporation | $1,355.00 | 2019-2020 | |
| Lumendi LLC | $975.76 | 2019-2020 | |
| Intuitive Surgical, INC. | $350.00 | 2021 | |
| Olympus America INC. | $174.85 | 2019-2020 | |
| Boston Scientific Corporation | $71.32 | 2019 | |
| Erbe USA INC | $17.68 | 2023 | Erbe Vio3 Apc3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hazem Hammad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.